Invention Grant
- Patent Title: Therapeutics directed against coronavirus
-
Application No.: US18301761Application Date: 2023-04-17
-
Publication No.: US11951174B2Publication Date: 2024-04-09
- Inventor: Sunanda Singh
- Applicant: Singh Biotechnology, LLC
- Applicant Address: US FL Lutz
- Assignee: Singh Biotechnology, LLC
- Current Assignee: Singh Biotechnology, LLC
- Current Assignee Address: US FL Lutz
- Agency: Matrix Law Group, LLP
- Agent Laura M. King
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61K38/16 ; A61K38/17 ; A61K47/64 ; A61P31/14

Abstract:
This invention provides compositions and methods to treat, prevent, and diagnose viral infections. The methods provided herein involve administering polypeptides of the invention to a subject in need thereof. The viral infections can be caused by a coronavirus such as SARS-CoV-1, SARS-CoV-2 or a variant thereof. It is contemplated that the polypeptide can be further linked to a compound, wherein the compound extends the serum half-life of the polypeptide.
Public/Granted literature
- US20230277681A1 THERAPEUTICS DIRECTED AGAINST CORONAVIRUS Public/Granted day:2023-09-07
Information query
IPC分类: